News
News

The latest updates from AFAR.

Grantee in the News: Matt Kaeberlein in Medium on The Dog Aging Project and Rapamycin

Sep 24
2018

Grantee in the News: Matt Kaeberlein in Medium on The Dog Aging Project and Rapamycin View MoreBACK

On September 19, 2018, Medium highlighted the research and insights of AFAR expert Matt Kaeberlein, Ph.D. on The Dog Aging Project and the potential of rapamycin to extend the lifespan and healthspan of dogs.

Dr. Kaeberlein is a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient.

Read “Furrever Young” here. Learn more about The Dog Aging Project in this recorded webinar here.





View MoreBACK TO TOP